Background. We examined relationships among positive, negative, and depressive symptoms in schizophrenia and major depression with psychosis.
types are interrelated may lead to refined nosologic descriptions of schizophrenia. For example, this understanding could clarify how to differentiate negative symptom schizophrenia from schizophrenia with a superimposed major depression from schizo affective disorder. Moreover, understanding these relationships may have direct treatment implications, such as defining when depressive symptoms in schizophrenia simply represent an extension of the underlying psychotic process, perhaps manifesting in severe negative symptoms, or when they represent a major depressive episode that warrants anti depressant therapy. To date, most studies examining the various symptom associations in schizophrenia concentrated on relationships between negative and depressive symptoms. These studies suggest that depressive symptoms are strongly associated with negative symptoms, particularly those associated with avolition/apathy and anhedonia/asociality (Whiteford et a!, 1987; Kitamura & Suga, 1991) . However, only a few studies examined this association in non-schizophrenic patients. Kitamura & Suga (1991) observed that more severe negative symptoms were also associated with a greater severity of depressive symptoms in patients with schizoaffective disorder, major depression, and bipolar disorder.
These findings suggest that negative and depressive symptoms may be describing similar phenomeno logical characteristics in psychotic patients. A potential confounding variable in these studies was the use of chronically ill, medicated patients since previous reports suggest that neuroleptics can produce behavioural changes that mimic negative symptoms (Harrow et a!, 1994 tend to decrease, rather than increase, following neuroleptic treatment (Knights & Hirsch, 1981) . The reasons for this association are unclear. Depression may be an integral part of schizophrenia which is present during the acute phase of illness but not easily recognised (Hirsch, 1982) . If so, is the more severe endogenous depression associated with a major affective syndrome like psychotic depression independent of positive psychotic symptoms? Examining relationships between these symptoms in disorders other than schizophrenia could provide information on the diagnostic specificity of this association, and the potential influence of varying levels of depression on psychosis. There are no studies to date which have examined this relationship in non-schizophrenic psychotic patient samples. Patients with psychotic depression may contribute to this question since they often exhibit psychotic symptoms as severe as those found in schizophrenia along with a greater severity of depression.
Given these considerations, we examined associations between negative, positive psychotic, and depressive symptoms in patients with schizo phrenia and psychotic depression. We examined the potential influence of varying levels of depression on these associations by comparing correlations in patients with schizophrenia v. those with psychotic depression. These groups were expected to vary considerably in the severity of depressive, but not psychotic symptoms, allowing us to examine the effects of depression on associations between depressive and psychotic symptoms.
Subjects the 17-item Hamilton Depression Rating Scale (HDRS) (Hamilton, 1960) . The SANS is comprised of five subscales measuring affective flattening, alogia, avolition/apathy, anhedonia/asociality, and attention. Ratings were performed in a semi structured interview by research assistants with good inter-rater reliability (ICC > 0.7 for most items) who were blind to SCID diagnosis. Efforts were made to evaluate patients immediately after admission, although in some cases the interview took place within the first 72 hours following admission. Hence, some patients may have received medication for a maximum of 72 hours prior to the interview.
Statistical analyses
Analyses were performed using the Statistical Analysis System (SAS; SAS Institute, Cary, NC, 1991); t-tests were used to assess potential differences between groups on demographic and symptom variables. Where appropriate, x@analyses assessed differences in the distribution of demographic variables. Pearson product moment correlations were then used to examine hypothesised associations in the two groups. Significance levels were adjusted to control for multiple comparisons. For example, a significance level of P= 0.016 was used for correlationsamong positive, negative, and depressive symptoms in each group. To assess the hypothesised relationship between specific SANS subscales and severity of depression, the level of significance was adjusted (P=0.005) for ten comparisons (total HDRS with five SANS subscales in two groups). Finally, given the relatively small sample sizes in the two groups, a power analysis was performed to assess the strength of associations found.
Results
Means and s.d. for demographic variables are presented in Table 1 ; no significant differences between the two diagnostic groups were found. Means and s.d. of the HDRS, SANS, and SAPS are also reported in the table. There were significant group differences on the total HDRS (t = 2.9, d.f. =41, P<0.0l), but not the SANS or SAPS total scores. Groups did not differ on the SANS subscale scores of avolition/apathy or anhedonia/asociality.
Correlations between the HDRS and SANS were found in both the psychotic depression (r=0.51, P<0.012) and schizophrenic (r=0.65, P<0.012) groups. Analysis of HDRS and SAPS total scores resulted in significant correlations between them in patients with schizophrenia (r=0.69, Pcz0.007), but
Method
Patients (n = 42) aged 15 and older with no prior psychiatric admissions, meeting DSM-III-.R criteria for a diagnosis of major depression with psychotic features (n = 25), or a schizophrenia-spectrum disorder (i.e. schizophrenia, schizophreniform disorder, psychosis not otherwise specified) (n = 17), were recruited from the in-patient psychiatric units of the University of Cincinnati Hospital as part of the University of Cincinnati First-Episode Psychosis Project (Strakowski eta!, 1995). Only patients with psychotic symptoms including formal thought disorder, hallucinations, delusions, or grossly disorganised behaviour, and no previous psychiatric admissions or pharmacologic treatment were included in the study. Diagnoses were determined independently from symptom ratings using the StructurÃ §d Clinical Interview for DSM-III-R (SCIDâ€"P)(Spitzer et a!, 1990), performed by psychiatrists (SLM, SMS, PEK, and SAW) who had established good inter-rater reliability (kappa = 0.94).
Symptom assessments
Symptoms were assessed using the Scale for the Assessment of Negative Symptoms (SANS; Andreasen, 1982) (Sins et a!, 1988) . In order to determine whether a given medication is more efficacious in alleviating negative v. depressive symptoms, the two should first be clearly defined. For example, the atypical antipsychotics clozapine and risperidone have both demonstrated efficacy in the treatment of negative symptoms (Carpenter, 1995) . However, it may be that some of this negative symptom efficacy is secondary to their antidepressant effects.
Depressionand positivesymptoms
Our findings of a positive association between depressive and positive symptoms are consistent with the report of Norman & Malla (1994), but not that of Doilfus et a!(1993) . Reasons for this contradictory finding relative to the latter study are unclear, although they may be due to different patient populations or the use of different rating scales. Nonetheless, the association between positive psychotic symptoms and depressive symptoms in schizophrenia, but not in psychotic depression suggests that, in the former, depressive symptoms may represent an alternative expression of the underlying psychotic process or an integral part of the schizophrenic state (Hirsch, 1982) , whereas in the latter, these symptoms may be part of the major affective syndrome. Alternatively, these differences may simply reflect that associations between these two symptom types are influenced by the severity of the depressive symptomatology. One issue not addressed in the present study relates to why certain positive symptoms like auditory hallucinations and persecutory delusions appear to be associated with depression while others are not (Barnes et a!, 1989; Norman & Malla, 1994) .Limitations based on sample size prohibited this analysis in the present study, however, examination of this issue in future studies is warranted. There are several important limitations of this study that should be considered when interpreting these results. First, the number of subjects is relatively small. However, our power analysis supports a sufficient level of statistical power to determine significant results. Second, although raters Further analysis of SANS subscales revealed that in both groups, HDRS scores correlated significantly (adjusted P = 0.005) with the SANS subscale anhedonia/asociality (psychotic depression, r=0.62, P<0.003; schizophrenia, r=0.73, P<0.002). avolition/apathy correlated with depression in patients with psychotic depression (r= 0.63, P<zO.OOl), but not schizophrenia (r=0.66, P<zO.01).
The relative small sample size prompted a power analysis which revealed that correlations of 0.60 yielded a power of 0.70â€"0.80, which is sufficient to reveal significant results.
Discussion

Depressionand negativesymptoms
These results confirm previous findings of correlations between depressive and negative symptoms in hospitalised patients (Whiteford et a!, 1987; Kitamura & Suga, 1991) , and suggest this relationship is limited to negative symptoms associated with poor motivation, social withdrawal, and anhedonia. Since we controlled for long-term exposure to pharmacotherapy, these results do not appear to be influenced by such drug effects. This were blind to diagnosis, the same rater was responsiblefor assessingboth negativeand depressive symptoms. The differences observed in symptom severity and their associations between the two diagnostic groups suggest this potential rater bias was minimal. Third, differences in the range of symptom severity scores between groups may have influenced correlations between scales. However, the standard deviations of these scores did not differ between groups, suggesting this potential effect was also minimal. Finally, although all patients were recruited for this study within 72 hours of admission, some had received medication during this interval. However, examination of mean ratings for each of the scales indicates the effects of medication were minimal.
These results suggest further study is necessary to clearly understand differences and similarities between depressive and negative symptoms in psychotic disorders, and to determine why positive symptoms appear to be associated with depression in schizophrenia but not psychotic depression.
